Salesforce (CRM) is set to report fiscal third-quarter results tomorrow after the close of trading, and Wedbush Securities is ...

Musk reacted on his X social media platform to the ruling on Monday by Court of Chancery Judge Kathleen McCormick.

Wedbush has assumed coverage of Voyager Therapeutics (VYGR) with an outperform rating, highlighting the company’s TRACER ...

Investing.com -- Wedbush analysts expect tech stocks to end the year strongly with a “Santa rally,” citing positive catalysts ...

Tesla pledges to keep fighting for Elon Musk's $65 billion pay to be restored, a battle that could make it all the way to the ...

Tesla's (TSLA) board is eventually expected to get Chief Executive Elon Musk his hefty pay package "one way or another" despite a Delaware judge's fresh ruling against the plan, Wedbush Securities ...

In a report released today, Daniel Ives from Wedbush maintained a Buy rating on Salesforce (CRM – Research Report), with a price target of ...

Stellantis' next CEO faces a mountain of challenges, including overpriced vehicles with little demand, EVs arriving as the ...

Judge Kathleen McCormick described the electric car maker’s legal arguments as ‘creative’ but ‘fatally flawed’ ...

Wedbush upgraded Voyager Therapeutics (VYGR) to Outperform from Neutral with a price target of $11, up from $7, after ...

Some panned the billionaire for overspending on Twitter, but the platform is winning him favor with Donald Trump and ...

Shares of Janux Therapeutics skyrocketed Tuesday on "unprecedented" results for an experimental prostate cancer treatment.